1. Home
  2. VIRC vs INO Comparison

VIRC vs INO Comparison

Compare VIRC & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VIRC

Virco Manufacturing Corporation

HOLD

Current Price

$6.11

Market Cap

99.1M

ML Signal

HOLD

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$0.70

Market Cap

100.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIRC
INO
Founded
1950
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
99.1M
100.4M
IPO Year
1995
1999

Fundamental Metrics

Financial Performance
Metric
VIRC
INO
Price
$6.11
$0.70
Analyst Decision
Hold
Buy
Analyst Count
1
4
Target Price
$7.30
$6.75
AVG Volume (30 Days)
33.6K
3.4M
Earning Date
04-08-2026
05-08-2026
Dividend Yield
1.65%
N/A
EPS Growth
N/A
54.18
EPS
N/A
N/A
Revenue
$199,652,000.00
$42,220,086.00
Revenue This Year
N/A
$20,156.19
Revenue Next Year
$19.77
$421.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.37
52 Week Low
$5.16
$0.56
52 Week High
$9.07
$2.86

Technical Indicators

Market Signals
Indicator
VIRC
INO
Relative Strength Index (RSI) 51.86 23.53
Support Level $6.01 N/A
Resistance Level $6.37 $1.24
Average True Range (ATR) 0.15 0.06
MACD 0.00 -0.04
Stochastic Oscillator 88.61 21.85

Price Performance

Historical Comparison
VIRC
INO

About VIRC Virco Manufacturing Corporation

Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

Share on Social Networks: